Health CanadaType I
ELAVIL 10mg: NDMA impurity
Published: January 26, 2022Recall ID: 63855Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Stopping amitriptyline may lead to mild withdrawal symptoms.Contact your health care provider if you have taken a recalled product and you have concerns about your health. Ask your pharmacist if you are unsure whether you are taking a recalled product.Contact the company if you have questions about the recall:Apotex Inc. via Sedgwick by calling at 1-888-266-7914, or by email at apotex5117@sedgwick.comAA Pharma at 1-905-669-1565Report any health product-related side effects or complaints to Health Canada.
Affected Products
Elavil 10mg
Additional Source Details
| Field | Value |
|---|---|
| N I D | 63855 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/elavil-10mg-ndma-impurity |
| Issue | Product safety |
| Title | ELAVIL 10mg: NDMA impurity |
| Product | Elavil 10mg |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-01-26 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Stopping amitriptyline may lead to mild withdrawal symptoms.Contact your health care provider if you have taken a recalled product and you have concerns about your health. Ask your pharmacist if you are unsure whether you are taking a recalled product.Contact the company if you have questions about the recall:Apotex Inc. via Sedgwick by calling at 1-888-266-7914, or by email at apotex5117@sedgwick.comAA Pharma at 1-905-669-1565Report any health product-related side effects or complaints to Health Canada. |